Announcements Trials
Browse Landscape

Phase

Phase 2 32Phase 1/2 16Phase 1 4Phase 3 2

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 2Dermatologic 1Breast 1

Conditions

Diffuse Intrinsic Pontine Glioma 2Skin Neoplasms 1Neoplasms 1Melanoma 1Glioma 1Breast Neoplasms 1

Interventions

pembrolizumab 109Paclitaxel 65Cyclophosphamide 65Cisplatin 60Carboplatin 56Gemcitabine 48Radiotherapy 45Nivolumab 44fludarabine 38Docetaxel 38Pemetrexed 33Dexamethasone 32Capecitabine 32Lenalidomide 26fludarabine phosphate 25Rituximab 25Radiation 25Ipilimumab 25Doxorubicin 25Irinotecan 24Bevacizumab 24Azacitidine 24Vorinostat 23Vincristine 22Cytarabine 22Temozolomide 20Etoposide 20Oxaliplatin 19Fluorouracil 19atezolizumab 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Has results × Panobinostat × Clear all
NCT04804709 2025-06-08

Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG)

Columbia University

Phase 1 Terminated
5 enrolled 11 charts
CNS

Diffuse Intrinsic Pontine Glioma

NCT02717455 2024-04-25

PBTC-047

Pediatric Brain Tumor Consortium

Phase 1 Completed
53 enrolled 25 charts
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

NCT02032810 2023-01-20

Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
17 enrolled 12 charts
Dermatologic

Melanoma, Skin Neoplasms

NCT00632489 2015-06-08

LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients

SCRI Development Innovations, LLC

Phase 1 Completed
20 enrolled 5 charts
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡